维普期刊资源整合服务平台（V6.5）

116篇 您的检索式：作者名="FERLINI C"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Synergistic antiproliferative activity of tamoxiten and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis显示文摘	Ferlini C Scambia G Distetam M	1997	Br J Cancer1997，75，6：	1
2	New taxanes in development 显示文摘	FERLINI C GALLO D SCAMBIA G	2008	Expert Opin lnvestig Drugs2008，17，3：	1
3	Antitumour activity of the silybin-phosphatidylcholine complex,IdB 1016,against human ovarian cancer显示文摘	Gallo D Giacomelli S Ferlini C Raspaglio G Apollonio P Prislei S Riva A Morazzoni P Bombardelli E Scambia G		0，，：	1
4	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistancein ovarian cancer patients显示文摘	Mozzet ti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
5	Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance显示文摘	Ferlini C Raspaglio G Mozzetti S	2003	Mol Pharmacol2003，64，1：	1
6	Synergistic antiproliferative activity of tamoxifen and docetaxed on three oestrogen receptomegaive cancer cell Lines is mediated by induction of apoptosis显示文摘	Ferlini C Scambia G Distefano M	1997	Br J Cancer1997，75，：	1
7	Class I11 beta-tubulin overex- pression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
8	Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis显示文摘	Ferlini C Scambia G Distefano M	1997	Br J Cancer1997，75，6：	1
9	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
10	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
11	Class Ⅲβ-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
12	Class Ⅲ beta-tubulin over expression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	MOZZETTI S FERLINI C CONCOLINO P	2005	Clin Cancer Res2005，11，1：	1
13	Class Ⅲ betatubulin overexpression is a prominent mechanism of paditaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
14	Herpes virus microRNA expression and significance in serous ovarian cancer显示文摘	Pandya D Mariani M McHugh M Andreoli M Sieber S He S Dowell-Martino C Fiedler P Scambia G Ferlini C	2014	PLoS One2014，9，11：	1
15	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
16	The epithelial-mesen ehymal transition and the estrogen-signaling in ovarian cancer显示文摘	Gallo D Ferlini C Scambia G	2010	CurrDrugTargets2010，11，4：	1
17	Synergistic antiproliferative activity of tamoxifen and docetaxed on three oestrogen receptornegative cancer cell lines is mediated by the induction of apoptosis 显示文摘	Scambia G Distefano M	1997	Br J Cancer1997，75，：	1
18	Class Ⅲ beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
19	Class Ⅲ betatubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients 显示文摘	Mozzetti S Ferlini C Concolino P	2005	Clin Cancer Res2005，11，1：	1
20	Anti-tumour activity of apanel of taxanes toward a cellular model of human cervical cancer显示文摘	Gallo D Ferlini C Distefano M	2000	Cancer Chemother Phannacol2000，45，2：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示